Notify me when FEDERATED HERMES, INC. files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| NERV | MINERVA NEUROSCIENCES, INC. | COMMON STOCK | 20% | $35,502,800 | +$30,394,980 | 9,392,275 | +595% | Federated Hermes, Inc. | 22 Dec 2025 |
| FBRX | Forte Biosciences, Inc. | COMMON STOCK | 13% | $18,692,393 | +$1,791,458 | 1,635,380 | +11% | Federated Hermes, Inc. | 30 Sep 2025 |
| ARCT | Arcturus Therapeutics Holdings Inc. | COMMON STOCK | 12% | $20,251,313 | 3,303,640 | Federated Hermes, Inc. | 31 Dec 2025 | ||
| ATYR | aTYR PHARMA INC | COMMON STOCK | 11% | $55,463,739 | -$21,682,577 | 10,544,437 | -28% | Federated Hermes, Inc. | 30 Sep 2025 |
| SCYX | SCYNEXIS, INC. | COMMON STOCK | 8.4% | $2,367,278 | -$1,060,843 | 3,533,250 | -31% | Federated Hermes, Inc. | 31 Dec 2025 |
| SSTI | SOUNDTHINKING, INC. | COMMON STOCK | 7.8% | $12,062,500 | 1,000,000 | Federated Hermes, Inc. | 30 Sep 2025 | ||
| MGPI | MGP INGREDIENTS, INC. | COMMON STOCK | 6.8% | $34,938,696 | +$8,166,309 | 1,437,836 | +31% | Federated Hermes, Inc. | 31 Dec 2025 |
| EYPT | EYEPOINT PHARMACEUTICALS, INC. | COMMON STOCK | 6.7% | $27,182,750 | 4,599,450 | Federated Hermes, Inc. | 30 Jun 2025 | ||
| OVID | Ovid Therapeutics Inc. | COMMON STOCK | 5.9% | $12,611,581 | 7,737,166 | Federated Hermes, Inc. | 31 Dec 2025 | ||
| TTEC | TTEC HOLDINGS, INC. | COMMON STOCK | 5.2% | $9,862,428 | 2,541,863 | Federated Hermes, Inc. | 31 Dec 2025 | ||
| IDYA | IDEAYA Biosciences, Inc. | COMMON STOCK | 3.9% | $117,393,162 | 3,395,771 | Federated Hermes, Inc. | 31 Dec 2025 | ||
| SPCE | VIRGIN GALACTIC HOLDINGS, INC. | COMMON STOCK | 0.51% | $657,253 | -$5,465,650 | 209,985 | -89% | Federated Hermes, Inc. | 31 May 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|